Jeffery Wood v. Bryan Collier

836 F.3d 534, 2016 U.S. App. LEXIS 16693, 2016 WL 4750879
CourtCourt of Appeals for the Fifth Circuit
DecidedSeptember 12, 2016
Docket16-20556
StatusPublished
Cited by50 cases

This text of 836 F.3d 534 (Jeffery Wood v. Bryan Collier) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jeffery Wood v. Bryan Collier, 836 F.3d 534, 2016 U.S. App. LEXIS 16693, 2016 WL 4750879 (5th Cir. 2016).

Opinion

PATRICK E. HIGGINBOTHAM, Circuit Judge:

In 2012, Texas adopted its current execution protocol: a single, five-gram dose of pentobarbital to induce death. Five men convicted of murder and sentenced to die by lethal injection ask this Court to stay their impending executions based on an earlier and separate case between Texas and two death row prisoners. Three of the five received stays from the Texas Court of Criminal Appeals on state habeas petitions presenting claims not at issue here. The remaining two argue that Texas is obliged by the Eighth Amendment’s prohibition on cruel and unusual punishment and the Fourteenth Amendment’s guarantee of equal protection under the law to retest the execution drug to assure it does not present a high risk of unnecessary pain. We are not persuaded these prisoners have made the showing required for a stay pending appeal and DENY their motion for a stay of execution.

*537 I.

A.

Appellants filed this 42 U.S.C. § 1983 civil suit on August 12, 2016 in the United States District Court for the Southern District of Texas, alleging violations of the First, Eighth, and Fourteenth Amendments, and sought a preliminary injunction that would have granted the ultimate relief requested in the complaint. They asserted that: (1) Texas’s use of compounded pento-barbital absent re-testing shortly before execution violates the Eighth and Fourteenth Amendments by creating a substantial risk of severe pain; (2) Texas’s refusal to disclose elements of its execution protocol violated Appellants’ First, Eighth, and Fourteenth Amendment rights to be free from cruel and unusual punishment, due process, notice, an opportunity to be heard, and access to the courts; (3) voluntary re-testing of the pentobarbital that will be used to execute plaintiffs in another suit created a constitutional right to such re-testing for all prisoners; and (4) the lack of a requirement that Texas notify the Appellants of any changes to the drugs or to the lethal injection protocol that will be used to carry out their sentences impairs protection of their right to be free from cruel and unusual punishment and to due process under the Eighth and Fourteenth amendments.

The State moved to dismiss the complaint on August 15, 2016, arguing that all except the equal protection claim were time-barred and all claims failed as a matter of law. At a hearing the following day, the district court denied the request for a preliminary injunction and dismissed the complaint for failure to state a claim. The next day the district court denied a stay pending appeal.

B.

The prisoners’ suit now before us presents as the latest in a series of cases targeting capital punishment. In the recent case before this court of Jordan v. Fisher, a group of Mississippi death row inmates challenged that state’s use of pentobarbital as the first drug in a so-called “three-drug cocktail.” 1 There, the Jordan prisoners complained to the district court that pento-barbital was not a sufficiently fast acting barbiturate to guarantee anesthetization prior to the introduction of vecuronium bromide and potassium chloride, urging as the alternative a single, lethal dose of a barbiturate.

Since 2012 the State of Texas has done just that — execution via a single-drug protocol utilizing a five-gram dose of pento-barbital. Texas originally used pentobarbi-tal purchased from a pharmaceutical firm in its executions. However in 2011, Lund-beck, the Danish pharmaceutical firm that produces manufactured pentobarbital, refused to supply the drug to states that execute by lethal injection. 2 In response, in September 2013, Texas began purchasing pentobarbital compounded by pharmacies. 3 Texas alleges, and Appellants do not dispute, that Texas has used compounded pentobarbital to execute thirty-two prisoners since 2013 without issue. Even so, Appellants’ primary contention is that Texas’s use. of compounded pentobarbital creates significant risks of unnecessary pain, and thus the state should be compelled to retest the drug shortly before execution.

*538 II.

Appellants request a stay of execution pending review in this Court of the district court’s dismissal of their suit and denial of a stay pending appeal. A stay of execution is an equitable remedy that is not available as a matter of right. 4 In determining whether to grant a stay pending appeal, this Court weighs:

(1) whether the stay applicant has made a strong showing that he is likely to succeed on the merits; (2) whether the applicant will be irreparably injured absent a stay; (3) whether issuance of a stay will substantially injure the other parties interested in the proceeding; and (4) where the public interest lies. 5

“[Bjecause it is settled that capital punishment is constitutional, ‘[i]t necessarily follows that there must be a [constitutional] means of carrying it- out.’ ” 6 The Court has repeatedly held that lethal injection is a permissible method of execution. 7 While the Eighth Amendment does not require that execution be painless, 8 it does prohibit “serious illness and needless suffering” where there exists an alternative that is “feasible, readily implemented, and in fact significantly reduce[s] a substantial risk of severe pain.” 9 The Amendment secures a right to be free from methods of execution that create “a risk that is sure or very likely to cause serious illness and needless suffering, and give rise to sufficiently imminent dangers.” 10 Stated differently, “there must be a substantial risk of serious harm, an objectively intolerable risk of harm that prevents prison officials from pleading they were subjectively blameless for purposes of the Eighth Amendment.” 11

C.

The Equal Protection Clause of the Fourteenth Amendment is “essentially a direction that all persons similarly situated should be treated alike.” 12 Its basics are rote: “[e]qual protection does not require that all persons be dealt with identically, but it does require that a distinction made *539 have some relevance to the purpose for which the classification is made.” 13 In assessing an equal protection claim, “[s]trict scrutiny is appropriate only where a government classification implicates a suspect class or a fundamental right.” 14

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
836 F.3d 534, 2016 U.S. App. LEXIS 16693, 2016 WL 4750879, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jeffery-wood-v-bryan-collier-ca5-2016.